趋化因子CXCL12/CXCR7趋化轴在肿瘤中的研究进展
Research Progress of Chemokine CXCL12/CXCR7 Chemotactic Axis in Tumor
DOI: 10.12677/ACM.2021.113172, PDF,   
作者: 姜兆雨:滨州医学院,山东 滨州
关键词: 肿瘤CXCL12CXCR7CXCL12/CXCR7趋化轴Tumor CXCL12 CXCR7 CXCL12/CXCR7 Chemotactic Axis
摘要: 近年来,多种研究表明CXCL12/CXCR7趋化轴在肿瘤的发生、发展及演变过程中发挥着重要作用,CXCL12/CXCR7趋化轴能促进肿瘤细胞的生长和增殖,增强肿瘤细胞的黏附能力和促进肿瘤新生血管的生成,参与肿瘤细胞的转移过程。趋化因子受体CXCR7作为趋化因子CXCL12的第二受体,在肿瘤的进展过程中发挥着重要作用,CXCL12/CXCR7趋化轴有望成为肿瘤分子靶向治疗的新途径。
Abstract: In recent years, various studies have shown that CXCL12/CXCR7 chemotactic axis plays an im-portant role in the occurrence, development and evolution of tumors. CXCL12/CXCR7 chemotactic axis can promote the growth and proliferation of tumor cells, enhance the adhesion ability of tumor cells and promote the generation of tumor neovascularization, and participate in the metastasis of tumor cells. CXCR7, as the second receptor of CXCL12, plays an important role in the progression of tumors. The CXCL12/CXCR7 chemotactic axis is expected to become a new way for tumor molecular targeted therapy.
文章引用:姜兆雨. 趋化因子CXCL12/CXCR7趋化轴在肿瘤中的研究进展[J]. 临床医学进展, 2021, 11(3): 1193-1198. https://doi.org/10.12677/ACM.2021.113172

参考文献

[1] Stone, M.J., Hayward, J.A., Huang, C., Huma, Z.E. and Sanchez, J. (2017) Mechanisms of Regulation of the Chemokine-Receptor Network. International Journal of Molecular Sciences, 18, Article No. 342. [Google Scholar] [CrossRef] [PubMed]
[2] 冉黎婧, 史明霞, 洪敏. 间充质干细胞归巢机制研究进展[J]. 医学研究生学报, 2014(4): 423-426.
[3] Janssens, R., Proost, P. and Sofie, S. (2018) Pathological Roles of the Homeostatic Chemokine CXCL12. Cytokine & Growth Factor Reviews, 44, 51-68. [Google Scholar] [CrossRef] [PubMed]
[4] Long, Y., Jiang, Y., Zeng, J., Dang, Y., Chen, Y., Lin, J., Wei, H., Xia, H., Long, J., Luo, C., Chen, Z., Huang, Y. and Li, M. (2020) The Expression and Biological Function of Chemokine CXCL12 and Receptor CXCR4/CXCR7 in Placenta Accreta Spectrum Disorders. Journal of Cellular and Molecular Medicine, 24, 3167-3182. [Google Scholar] [CrossRef] [PubMed]
[5] Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., et al. (2010) CXCL12/CXCR4/CXCR7 Chemokine Axis and cancer Progression. Cancer and Metastasis Reviews, 29, 709-722. [Google Scholar] [CrossRef] [PubMed]
[6] Harriague, J., Thelen, M., Infantino, S., Chow, K.Y.C., Harriague, J., Moepps, B., et al. (2005) The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes. The Journal of Biological Chemistry, 280, 35760-35766. [Google Scholar] [CrossRef
[7] Benredjem, B., Mélanie, G., Rhainds, D., St.-Onge, G. and Heveker, N. (2017) Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12. Journal of Biological Chemistry, 292, 31-42. [Google Scholar] [CrossRef
[8] Chen, Q., Zhang, M., Li, Y., Xu, D., Wang, Y., Song, A., et al. (2015) CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4. Stem Cells, 33, 2574-2585. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, C., Chen, W. and Shen, J. (2018) CXCR7 Targeting and Its Major Disease Relevance. Frontiers in Pharmacology, 9, Article No. 641. [Google Scholar] [CrossRef] [PubMed]
[10] 袁泉, 许丞, 张翔, 卢东, 张捷. 膀胱癌组织中CXCR4和CXCR7的表达及临床意义[J]. 现代生物医学进展, 2016, 16(27): 5273-5275, 5292.
[11] Tarnowski, M., Liu, R., Wysoczynski, M., Ratajczak, J., Kucia, M. and Ratajczak, M.Z. (2010) CXCR7: A New SDF-1-Binding Receptor in Contrast to Normal CD34+ Progenitors is Functional and Is Expressed at Higher Level in Human Malignant Hematopoietic Cells. European Journal of Haematology, 85, 472-483. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K.J., et al. (2008) The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer. Journal of Biological Chemistry, 283, 4283-4294. [Google Scholar] [CrossRef
[13] 金栋. CXCL12/CXCR7轴对人肝癌细胞增殖与迁移能力的影响[D]: [硕士学位论文]. 银川: 宁夏医科大学, 2011.
[14] Long, P., Sun, F., Ma, Y. and Huang, Y. (2016) Inhibition of CXCR4 and CXCR7 for Reduction of Cell Proliferation and Invasion in Human Endometrial Cancer. Tumor Biology, 37, 7473-7480. [Google Scholar] [CrossRef] [PubMed]
[15] 辛琪, 张娜, 温丽坤, 张勤, 张传山. 趋化因子受体CXCR7通过VEGF促进胃癌生长[J]. 世界华人消化杂志, 2018, 26(11): 639-647. [Google Scholar] [CrossRef
[16] Stacer, A.C., Fenner, J., Cavnar, S.P., Xiao, A., Zhao, S., Chang, S.L., et al. (2016) Endothelial CXCR7 Regulates Breast Cancer Metastasis. Oncogene, 35, 1716-1724. [Google Scholar] [CrossRef] [PubMed]
[17] 辛琪, 张勤, 张娜, 温丽坤, 刘贵秋, 张传山, 等. 趋化因子配体12、趋化因子受体7在肠型胃癌中的表达与淋巴结和肝脏转移的关系[J].中华消化杂志, 2016, 36(11): 740-745.
[18] Wang, H., Tao, L., Qi, K., Zhang, H., Feng, D., Wei, W., et al. (2015) CXCR7 Functions in Colon Cancer Cell Survival and Migration. Experimental & Therapeutic Medicine, 10, 1720-1724. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, H.X., Tao, L.Y., Qi, K., Zhang, H.Y., Feng, D., Wei, W.J., et al. (2015) Role of CXC Chemokine Receptor Type 7 in Carcinogenesis and Lymph Node Metastasis of Colon Cancer. Molecular & Clinical Oncology, 3, 1229-1232. [Google Scholar] [CrossRef] [PubMed]
[20] Sanchez-Martin, L., Estecha, A., Samaniego, R., Sánchez-Ramón, S., Ángel Vega, M. and Sánchez-Mateos, P. (2011) The Chemokine CXCL12 Regulates Monocyte-Macrophage Differentiation and RUNX3 Expression. Blood, 117, 88-97. [Google Scholar] [CrossRef] [PubMed]
[21] 李迪诺. CXCR7-CXCL12生物学轴在胃癌血管生成及侵袭转移中的分子机制研究[D]: [博士学位论文]. 济南: 山东大学, 2017.
[22] Liu, Y., Carson-Walter, E. and Walter, K.A. (2015) Targeting Chemokine Receptor CXCR7 Inhibits Glioma Cell Proliferation and Mobility. Anticancer Research, 35, 53-64.
[23] Lin, L., Han, M.M., Wang, F., Xu, L.-L., Yu, H.-X. and Yang, P.-Y. (2014) CXCR7 Stimulates MAPK Signaling to Regulate Hepatocellular Carcinoma Progression. Cell Death & Disease, 5, e1488. [Google Scholar] [CrossRef] [PubMed]
[24] 罗旭玮, 赵凯, 郭青龙. CXCR7的生物学功能及其在肿瘤发生发展中的作用研究进展[J]. 药学进展, 2016, 40(9): 695-699.
[25] 于利影, 黄红艳, 徐桂涛, 曹仕琼, 王坤. 趋化因子受体CXCR7在结直肠癌组织中的表达及临床意义[J]. 临床消化病杂志, 2016, 28(4): 235-239.
[26] 张建庆, 王珍. 趋化因子受体7在结直肠癌组织中的表达及其与患者远期生存率的相关性[J]. 中国煤炭工业医学杂志, 2019, 22(1): 75-78.
[27] 邱明远, 李健文, 叶青, 郑民华, 刘炳亚. RNA干扰CXCR7基因对结肠癌SW1116细胞增殖及迁移的影响[J]. 肿瘤, 2011, 31(5): 412-416.
[28] 王鑫, 陈玲, 孙飞, 陆航. RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究[J]. 中国生物工程杂志, 2014, 34(2): 14-20.
[29] Guillemot, E., Karimdjee-Soilihi, B., Pradelli, E., Benchetrit, M., Goguet-Surmenian, E., Millet, M.-A., et al. (2012) CXCR7 Receptors Facilitate the Progression of Colon Carcinoma within Lung Not within Liver. The British Journal of Cancer, 107, 1944-1949. [Google Scholar] [CrossRef] [PubMed]